menu
    • menu

    Company profile for NEXGEL Advanced Hydrogel Solutions

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NEXGEL Advanced Hydrogel Solutions is your skin friendly patch company! Our ultra-gentle, high-water content hydrogels are an excellent transdermal drug delivery system for a broad range of OTC and Cosmetic ingredients. Our hydrogels are more gentle because we don’t chemical cross-linking agents, instead, we use a unique electron-beam cross linking process to create the bond. Additionally, our hydrogels are more skin-friendl...
    NEXGEL Advanced Hydrogel Solutions is your skin friendly patch company! Our ultra-gentle, high-water content hydrogels are an excellent transdermal drug delivery system for a broad range of OTC and Cosmetic ingredients. Our hydrogels are more gentle because we don’t chemical cross-linking agents, instead, we use a unique electron-beam cross linking process to create the bond. Additionally, our hydrogels are more skin-friendly than many adhesive patches on the market, since we don’t use chemical adhesives to deliver our ingredients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NEXGEL Advanced Hydrogel SolutionsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2150 Cabot Blvd West, Suite B Langhorne, PA 19047
    Telephone
    Telephone
    215-702-8550
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nexgel.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NEXGEL To Release 2025 Q4 And Full Year Financials On March 31
    NEXGEL To Release 2025 Q4 And Full Year Financials On March 31

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262248/0/en/NEXGEL-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-31st.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Celularity Renews NEXGEL Partnership For Biomaterials Franchise
    Celularity Renews NEXGEL Partnership For Biomaterials Franchise

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254647/0/en/Celularity-Reiterates-Strategic-Commercialization-Partnership-with-NEXGEL-Focused-on-Building-Biomaterials-Franchise-with-Established-Commercial-Products-and-New-510-k-Pathway-Prod.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    NEXGEL Announces Terms to License & Acquire Regenerative Tech
    NEXGEL Announces Terms to License & Acquire Regenerative Tech

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254679/0/en/NEXGEL-Announces-Consideration-Terms-of-Agreement-to-License-and-Acquire-Portfolio-of-Commercial-Stage-Regenerative-Biomaterial-Products.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    NEXGEL Licenses & Acquires Regenerative Biomaterial Portfolio
    NEXGEL Licenses & Acquires Regenerative Biomaterial Portfolio

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252840/0/en/NEXGEL-Signs-Definitive-Agreement-to-License-and-Acquire-Transformative-Portfolio-of-Commercial-Stage-Regenerative-Biomaterial-Products.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    NEXGEL Secures $1.797M for Acquisition Set to Close in Q1 2026
    NEXGEL Secures $1.797M for Acquisition Set to Close in Q1 2026

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235380/0/en/NEXGEL-Announces-Financing-of-1-797-Million-Relating-to-an-Acquisition-Targeted-to-Close-in-the-First-Quarter-of-2026-Subject-to-the-Completion-of-Due-Diligence.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    NEXGEL Announces Spin-Off Of Drug Delivery Program Into Nexgelrx
    NEXGEL Announces Spin-Off Of Drug Delivery Program Into Nexgelrx

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203832/0/en/NEXGEL-Announces-Spin-Off-of-Drug-Delivery-Program-into-NexGelRx.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search